Can (18)F-FDG PET after first cycle chemotherapy predict the efficacy of therapy in Hodgkin's disease?
Rigacci
Luigi
L
Hematology Department, Azienda Ospedaliera Careggi and Universita degli Studi di Firenze, Florence, Italy. l.rigacci@dfc.unifi.it
Castagnoli
Antonio
A
Carpaneto
Andrea
A
Carrai
Valentina
V
Vaggelli
Luca
L
Matteini
Maria
M
D000970:Antineoplastic Agents / Q000008:administration & dosage; D005240:Feasibility Studies; D019788:Fluorodeoxyglucose F18; D006689:Hodgkin Disease / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000188:drug therapy; D006801:Humans; D011237:Predictive Value of Tests; D014055:Tomography, Emission-Computed; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D019788:Fluorodeoxyglucose F18